(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...
(Date:12/15/2009)... -- Aethlon Medical, Inc. (OTC Bulletin Board : ... Dr. Wayne Comper have joined the ... Both Dr. Schorey and Dr. Comper are leading ... owned subsidiary of Aethlon Medical, was recently formed ... medical device being advanced as an adjunct therapy ...
(Date:12/15/2009)... 15 The Center for Business ... is pleased to announce the full agenda ... and Reporting Congress . The forum will ... March 16-17, 2010. ,, Over 1,500 senior-level ... attended this premier event since its inception, ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2... novel,vaccine that uses immune cells as factories to produce ... breast cancers, say researchers at,The University of Texas M. ... is a protein often present / surexpressed in ... Breast Cancer Research,on Nov. 29, 2004, showed that the ...
... the journal Nature that the "missing" genes for tRNA ... together sequences in distant parts of the DNA genome. ... the Department of Molecular Biophysics and Biochemistry at Yale ... genome sequence. Nanoarchaeum equitans, is a member of a ...
... on successful animal studies, a novel,vaccine that uses immune ... way to treat some human breast cancers, say researchers ... [Ed : Her2/neu is a protein often ... published in the online journal, Breast Cancer Research,on Nov. ...
Other Biology News:A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 2A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 3Researchers find missing genes of ancient organism 2Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 2Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer 3...
... designed to rapidly and reliably amplify unknown ... Technology. APAgene provides hassle-free, ready-to use components, ... ingredients are provided in each kit. The ... for insert-end amplification of large clones such ...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
Bovine Calf Serum...
Biology Products:Biology NavigationMedical Navigation